11.04.24 -- What Can Clinical Researchers Learn From Commercial Product Launches?

Find several actionable strategies to help ensure medical advancements benefit all populations through diverse representation in clinical trials.

Patient enrollment is one of the biggest challenges for clinical trials in rheumatology. Discover how to accelerate recruitment and ensure retention using digital solutions.

The convergence of recent technological advancements and Diversity Action Plans holds great promise for creating more inclusive clinical trials. See why embracing diversity is important to clinical research.

Explore the importance of tailoring recruitment strategies to specific populations and leveraging diverse channels to reach potential participants.

By providing personalized services, Elligo aims to bolster patient engagement, improve retention rates in clinical trials, and expedite the completion of studies.

Creating new drugs or devices profoundly affects health and safety. See why it's vital for clinical research stakeholders — sponsors, CROs, and sites — to work together, meeting rigorous regulatory standards.

Sites juggle dozens of applications, which increases their workload and limits their capacity. Sites need an industry-wide single sign-on experience that brings key systems and applications under one roof.

The sponsor-site relationship relies on good faith, but late payments sow mistrust. Experts from BMS and CenExel Clinical Research explain how consolidating payment systems benefits both parties.

Patient-centric trials, advocated by the FDA, focus on offering choices to improve engagement, diversity, and data quality. Explore how expanding patient choice can benefit clinical trials.

Evolving compensation models, tax implications, and enhanced participant support are transforming clinical research. Find insights for ensuring ethical practices and improving healthcare outcomes.

To realize the full value of patient-centric solutions sponsors, sites and patients all need to be continually integrated from concept to trial completion.